Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

3articles mentioning drugs

6drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: TaVNS ×

TaVNS

This drug is selected. Its supporting articles are shown below.

Articles mentioning TaVNS

3 articles · page 1 of 1

Effect of non-invasive transcutaneous auricular vagus nerve stimulation (taVNS) on non-motor symptoms in multiple sclerosis: study protocol for a randomised, controlled trial

bmjopen · abstract · 2025-11-09 · 3 matching annotations

86.5%

taVNS taVNS University Medical Centre Greifswald relapsing remitting multiple sclerosis PwRRMS Transcutaneous auricular vagus nerve stimulation

…ms is needed. Transcutaneous auricular vagus nerve stimulation (taVNS) has been found to be a cognitive enhancer in preclinical resea…

Effects of transcutaneous auricular vagus nerve stimulation on perioperative anxiety in patients undergoing laparoscopic colorectal cancer surgery: a study protocol for a double-blind, prospective, single-centre, randomised controlled trial

bmjopen · abstract · 2026-04-06 · 2 matching annotations

85.1%

TaVNS Hospital Anxiety and Depression Scale colorectal tumour Jiangsu Cancer Hospital colorectal tumours

…e management. Transcutaneous auricular vagus nerve stimulation (TaVNS) represents a promising non-invasive intervention for anxiety a…

Effect and neurophysiological mechanisms of transcutaneous auricular vagus nerve stimulation (taVNS) for misophonia (taVNS-MISO): a study protocol for a single-centre double-blind randomised sham-controlled trial

bmjopen · abstract · 2026-05-20 · 1 matching annotations

88.6%

taVNS taVNS misophonia Brighton and Sussex Medical School ISRCTN ISRCTN79500062 transcutaneous auricular vagus nerve stimulation ER/GLP28/4

…ant misophonia are randomly allocated in a 1:1 ratio to receive taVNS or sham stimulation. The intervention will be self-administered…